© S. Priyadarshini
The COVID-19 crisis has primed governments to invest substantially in pandemic preparedness, a lesson that must be replicated to fight the alarming growth of drug resistance globally, write Manica Balasegaram* and Yogendra Kumar Gupta**.
Researchers say it is unclear on what basis the drugs were approved for ‘emergency use’.
© Sam Panthaky/AFP/Getty
As India’s pandemic case numbers inch towards the seven million mark, healthcare workers are feeling burnt out with unprecedented work load, anxiety and uncertainty.
© Sonu Mehta/Hindustan Times via Getty
COVID-19 is impacting women more than men, say Nitya Rao* and Jayashree Balasubramanian**.
Cell & molecular biology
Space & astronomy
Subhra Priyadarshini discusses issues concerning Indian science and scientists.
Stay connected with Nature India:
Sign-up to receive our e-alert update every two weeks to keep up with everything new on the portal.
Piramal Pharma Solutions,
Emergent materials, Kolkata
IBAB - Institute of bioinformatics and applied biotechnology, Bengaluru